Orfenace Tablet 100mg(2021-04-13)Health ProductsApr 13th, 2021 @ 12:00 AM
Basic Details
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Alert type: Drug Recall
Hazard classification: Type I
Summary
Product
Orfenace Tablets 100mg
Products
| Lot or serial number | Brand name | Companies | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|---|---|---|---|---|
| 10025A18,10025B18,10025A19,36664, 37342,37384,38058 | Orfenace Tablet 100mg |
| DIN 02047535 | Tablet | Orphenadrine Citrate 100mg |
Reason
Presence of N-methyl-N-nitroso-2-[(2-methylphenyl)phenylmethoxy]ethanamine (NMOA) above the acceptable concentration limit in affected lots.
Depth of distribution
Retailers, Wholesalers
Recall Monitor
Information presented from Recalls and Safety Alerts dataset, provided by the Government of Canada through the Open Government initiative and is subject to the Open Government License.
You can access this data free of charge via Recall Monitor, or through the Healthy Canadians website.
Get personalized SMS or Email notifications about recall alerts that matter by subscribing to Recall Monitor.
Recall Monitor is not endorsed by, or is an official product of the Government of Canada.
Made with in Vancouver, BC
© Mad Filaments Software Inc.